CoreCap Advisors’s Zomedica Corp. ZOM Stock Holding History

CoreCap Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$480	Hold	4,800	–	–	﹤0.01%	2867
2026 Q1	$573	Hold	4,800	–	–	﹤0.01%	2630
2025 Q4	$488	Hold	4,800	–	–	﹤0.01%	2709
2025 Q3	$379	Hold	4,800	–	–	﹤0.01%	2606
2025 Q2	$194	Buy	+4,800	New	+$194	﹤0.01%	2624
2025 Q1	–	Sell	-7,513	Closed	-$902	–	3349
2024 Q4	$902	Hold	7,513	–	–	﹤0.01%	2394
2024 Q3	$1.03K	Sell	7,513 -10,000	-57%	-$1.4K	﹤0.01%	2270
2024 Q2	$2.56K	Hold	17,513	–	–	﹤0.01%	1276
2024 Q1	$2.56K	Hold	17,513	–	–	﹤0.01%	2071
2023 Q4	$3.51K	Hold	17,513	–	–	﹤0.01%	603
2023 Q3	$2.93K	Sell	17,513 -20,000	-53%	-$3.88K	﹤0.01%	551
2023 Q2	$7.5K	Buy	+37,513	New	+$7.61K	﹤0.01%	573
2022 Q4	$8.56K	Hold	52,513	–	–	﹤0.01%	1590
2022 Q3	$11K	Sell	52,513 -27,330	-34%	-$7.23K	﹤0.01%	540
2022 Q2	$18K	Hold	79,843	–	–	﹤0.01%	1293
2022 Q1	$27K	Sell	79,843 -3,600	-4%	-$1.18K	﹤0.01%	546
2021 Q4	$26K	Buy	+83,443	New	+$37.6K	﹤0.01%	1237

Other funds holding ZOM

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

GCP

Gill Capital Partners Denver, Colorado $378M AUM 18.32% 1-Year Est. Return

Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

BWL

Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

CoreCap Advisors's ZOM Position: Q2 2026 in Review

CoreCap Advisors held its Zomedica Corp. (ZOM) position steady in Q2 2026 at 4,800 shares worth $480. The position accounts for ﹤0.01% of the portfolio, ranked #2867.

CoreCap Advisors first reported a position in ZOM in Q4 2021 and has held it in 17 quarters since. The position peaked at $27K in Q1 2022. 7 funds tracked by Wall St. Rank hold ZOM as of Q2 2026.

CoreCap Advisors held 4,800 shares of Zomedica Corp. worth $480 as of Q2 2026.
CoreCap Advisors left its Zomedica Corp. share count unchanged in Q2 2026.
Zomedica Corp. made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #2867 holding.
CoreCap Advisors first reported a position in Zomedica Corp. in Q4 2021 and has held it in 17 quarters since.
CoreCap Advisors's Zomedica Corp. position peaked at $27K in Q1 2022.
7 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.